Summary
Platelet aggregation response to epinephrine, dopamine, serotonin, adenosine diphosphate, arachidonic acid, and collagen was examined in seven patients with Huntington's disease and nine of their relatives. All patients, except for two cases that were in terminal states, showed enhanced response to all the stimulants, especially to dopamine and epinephrine. The platelet aggregation response in many relatives also deviated from the normal limit.
The relationship between platelet aggregation abnormality in Huntington's disease and the pathophysiology of the disease was discussed from the view of a generalized membrane defect hypothesis in Huntington's disease, and of disturbed cathecholamine metabolism, both in the CNS and periphery.
A possibility that platelet aggregation response examination will be a useful screening test of offspring at risk was proposed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aminoff MJ, Trenchard A, Turner P, Wood WG, Hills M (1974) Plasma uptake of dopamine and 5-hydroxytryptamine and plasma-catecholamine levels in patients with Huntington's chorea. Lancet II:1115–1116
Barbeau A (1979) Update on the biochemistry of Huntington's chorea. In: Chase TN, Wexler NS, Barbeau A (eds) Advances in neurology, vol 23. Raven Press, New York, pp 449–461
Belendiuk K, Belendiuk GW, Freedman DX (1980) Blood monoamine metabolism in Huntington's disease. Arch Gen Psychiatr 37:325–332
Bonilla E, Vargas-Urribarri N, Navas F (1978) Uptake of14C-dopamine in platelets of Huntington's chorea patients and symptom-free offspring. Lancet II:161–162
Bruyn GW, Bots GTAM, Dom R (1979) Huntington's chorea: Current neuropathological status. In: Chase TN, Wexler NS, Barbeau A (eds) Advances in neurology, vol 23. Raven Press, New York, pp 83–93
Butterfield DA, Markesbery WR (1981) Huntington's disease: A generalized membrane defect. Life Sci 28:1117–1131
Butterworth RF, Gonce M, Barbeau A (1977) Platelet dopamine uptake in Huntington's chorea and Gilles de la Tourette's syndrome: Effect of haloperidol. Can J Neurol Sci 4: 285–288
Diez-Ewald M, Bonilla E, Gonzalez JV (1980) Platelet aggregation, 5-hydroxytryptamine uptake and release in Huntington's chorea. Progr Neuro-Psychopharmacol 4:277–283
Kaiya H, Mori T, Moriuchi I, Namba M, Miyagawa T, Nakamura S (1981) Neurotransmitterrelated agents in the humor of Huntington's chorea. Jpn J Neuropsychopharmacol 3:35–43
Mann J, Chiu E (1978) Platelet monoamine oxidase activity in Huntington's chorea. J Neurol Neurosurg Psychiatr 41:809–812
McLean DR, Nihei T (1977) Uptake of dopamine and 5-hydroxytryptamine by platelets from patients with Huntington's chorea. Lancet I:249–250
Nathan I, Fleisher G, Dvilansky A, Livne A, Parola AH (1980) Membrane dynamic alterations associated with activation of human platelets by thrombin. Biochim Biophys Acta 598:417–421
Ohki K, Imai A, Nozawa Y (1980) Aggretation-induced alterations in human platelet membranes: A spin label study. Biochem Biophys Res Commun 94:1249–1255
Omenn GS, Smith L (1978) Platelet uptake of serotonin and dopamine in Huntington's disease. Neurology 28:300–303
Peyer M, Pletscher A (1981) Liberation of catecholamines and 5-hydroxytryptamine from human blood-platelets. Naunyn-Schmiedeberg's Arch Pharmacol 316:81–86
Stahl SM (1977) The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch Gen Psychiatr 34:509–516
Tanimoto Y, Hattori Y, Suzuki S (1980) Effect of fasting on platelet aggregation in the rabbit and the rat. Acta Haematol Jpn 43:856–863
Author information
Authors and Affiliations
Additional information
This paper was read at the 9th International Workshop of the World Federation of Neurology Research Group on Huntington's Chorea, Fuji, Shizuoka, Japan, in September 1981.
Rights and permissions
About this article
Cite this article
Muramatsu, Y., Kaiya, H., Imai, H. et al. Abnormal platelet aggregation response in Huntington's disease. Arch. F. Psychiatr. U. Z. Neur. 232, 191–200 (1982). https://doi.org/10.1007/BF02141780
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02141780